IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 137 filers reported holding IMMUNOGEN INC in Q1 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $72,000 | +22.0% | 10,159 | -65.0% | 0.03% | +75.0% |
Q4 2016 | $59,000 | +63.9% | 28,988 | +114.1% | 0.02% | +77.8% |
Q3 2016 | $36,000 | -30.8% | 13,538 | -20.5% | 0.01% | -10.0% |
Q2 2016 | $52,000 | -96.1% | 17,029 | -82.5% | 0.01% | -93.0% |
Q4 2015 | $1,324,000 | +47.8% | 97,566 | +56.6% | 0.14% | +62.5% |
Q2 2015 | $896,000 | -4.0% | 62,296 | -40.3% | 0.09% | -3.3% |
Q1 2015 | $933,000 | +177.7% | 104,266 | +89.3% | 0.09% | +184.4% |
Q4 2014 | $336,000 | -54.9% | 55,089 | -21.7% | 0.03% | -50.8% |
Q3 2014 | $745,000 | +39.5% | 70,364 | +56.1% | 0.06% | +54.8% |
Q2 2014 | $534,000 | – | 45,077 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |